Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio, the online open-access ...
Oct 8, 2013
0
1
An international collaboration of researchers from the U.S. Army Medical Research and Materiel Command (USAMRMC), Tunisia and France has demonstrated a high cure rate and remarkably few side effects in treating patients with ...
Feb 6, 2013
0
0
After more than two decades of research, scientists are testing the first vaccine against the deadliest form of a disease that infects more than 12 million people worldwide.
Apr 23, 2012
0
0
The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat ...
Feb 23, 2012
0
0
(Medical Xpress) -- A study published yesterday shows that a drug called fexinidazole could potentially be used to treat visceral leishmaniasis, a parasitic disease that kills 50 000 to 60 000 people a year in Africa, ...
Feb 2, 2012
0
0
The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces immune responses in patients with the infection.
Apr 15, 2021
0
9
The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières (MSF), the University of Gondar, and Addis Ababa University, open ...
Jan 17, 2019
0
1
Chemistry students are making compounds that may help treat diseases thanks to an open collaboration with the Drugs for Neglected Diseases initiative.
May 4, 2017
0
1
This week scientists, policy makers, and other global health actors will meet in Geneva for a Summit on Neglected Tropical Diseases (NTDs)—a group of diseases that overwhelmingly affect the poorest of the poor in low- and ...
Apr 21, 2017
0
0
An international collaborative of researchers has identified a mechanism that allows the leishmania parasite, which causes leishmaniasis, to evade the immune system and thereby produce infection. The study, published in Immunity, ...
Oct 12, 2016
0
1
